Serum MK‐422 and plasma angiotensin converting enzyme activity were measured during the introduction of enalapril therapy in eight patients with heart failure. In a second study of 16 patients, we recorded exercise tolerance, clinical status and haemodynamics before and after 12 weeks of placebo or...
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985;54: 305-12.Cleland JGF, Dargie HJ, Ball SG, Gillen G, Hodsman GP, Morton JJ, East BW, Robertson I, Ford I, Robertson JIS:...
” explained Dr Eric Velazquez, Berliner Professor of Cardiology at Yale School of Medicine and principal study investigator on the PIONEER-HF from which the data was drawn. “With the PIONEER-HF trial results-once acute heart failure is diagnosed, ...
Cody RJ: Clinical and hemodynamic experience with enalapril in congestive heart failure. Am J Cardiol 1985;55:36A-40ACody RJ. Clinical and hemodynamic experience with enalapril in congestive heart failure. Am J Cardiol 1985;55:36A-40A.Cody, RJ (1985) Clinical and hemodynamic experience with ...
By the end of the study, 68 subjects in the placebo group and 50 in the enalapril group had died-a reduction of 27% (p = 0.003). The entire reduction in total mortality (50%) was found in patients dying from progressive heart failure, whereas no difference was s...
It is an ACE inhibitor frequently used to treat hypertension and heart failure. Enalapril is prescribed by physicians to patients with symptomatic and asymptomatic congestive heart failure to reduce mortality and morbidity. Additionally, it is used to treat hypertensive emergencies and urgency. Enalapril...
Enalapril is generally well tolerated. The most troublesome adverse effect is dry persistent cough and the most clinically significant adverse effect is first-dose hypotension; the latter is more often seen in patients with heart failure. The small risk of enalapril-associated hyperkalaemia and acute...
Dickstein K, Till AE, Aarsland T, Tjelta K, Abrahamsen AM, Kristianson K, Gomez HJ, Gregg H and Hichens M (1987) The pharmacokinetics of enalapril in hospi- talized patients with congestive heart failure. Br J Clin Pharmacol 23:403- 410....
Research and market development ofenalapril; 依那普利研发及市场概况 2. Effect of Enalapril on paroxysmal atrial fibrillation in patients with essential hypertension; 依那普利治疗高血压并阵发性房颤的超声改变和疗效 3. Clinical Effects of Enalapril Combined with Valsartan for Chronic Heart Failure; ...
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Surviv... Efficacy and safety of eplerenone, enalapril, and eplerenone/enalapril combination therapy in patients with left ventricular hypertr... ...